Gary Schwartz: Monica Bertagnolli is poised to be a visionary NIH director

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

As Case Comprehensive Cancer Center’s new director, and on behalf of our membership, I applaud the Biden administration for tapping Monica Bertagnolli, MD, FASCO, as the second female director of the National Institutes of Health (NIH) and congratulate Dr. Bertagnolli on her candidacy. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Gary Schwartz, MD
Director, Case Comprehensive Cancer Center
Table of Contents

YOU MAY BE INTERESTED IN

In his first sit-down interview since beginning his role as FDA commissioner 17 days earlier, Marty Makary, a former Johns Hopkins surgeon and the only Trump pick for HHS whose confirmation received Democratic support, said he would speed up approvals for rare-disease treatments by reducing reliance on animal testing and shifting towards organoids and computational models. 
Gary Schwartz, MD
Director, Case Comprehensive Cancer Center

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login